The Company announces that it has granted incentive stock options to certain directors, officers, employees and consultants to purchase up to an aggregate of 7,455,000 common shares at a price of $0.235, being the closing price per share before the grant, and exercisable for a period of five years. The options are subject to vesting in 6 equal
[...]